Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis.
Porcari A, Milani P, Longhi S, Cappelli F, Vagnarelli F, Aimo A, Cipriani A, Gardini E, Marazia S, Monda E, Tini G, Musumeci B, Serenelli M, Cantone A, Lofiego C, Marini M, Vergaro G, Foti G, Musca F, Tomasoni D, Bonacchi G, Colio F, Sinigiani G, De Michieli L, Sturdà F, Pozzan M, Gentile P, Carigi S, Bartolotti M, Sena G, Ruotolo I, Sanna GD, Zanoletti M, Canepa M, Di Marco M, D'Elia E, Di Bella G, Driussi M, Imazio M, Perfetto F, Biagini E, Limongelli G, Metra M, Emdin M, Merlini G, Perlini S, Merlo M, Palladini G, Sinagra G.
Porcari A, et al. Among authors: sena g.
Eur J Heart Fail. 2025 Dec;27(12):2952-2960. doi: 10.1002/ejhf.70071. Epub 2025 Nov 29.
Eur J Heart Fail. 2025.
PMID: 41317156
Free PMC article.